116 results
8-K
EX-99.1
LLY
Lilly(Eli) & Co
30 Apr 24
Lilly Reports First-Quarter 2024 Financial Results and Raises Full-Year Revenue Guidance by $2 Billion, Highlights Pipeline Momentum
7:04am
delivery device for Mounjaro® was approved in the EU, adding to the UK approval earlier in 2024, for both the type 2 diabetes and chronic weight management
8-K
EX-99.1
rwlk34
6 Feb 24
Lilly Reports Strong Fourth-Quarter 2023 Financial Results and Provides 2024 Guidance
7:04am
8-K
EX-99.1
l1e4m0olzfobsg a7
2 Nov 23
Lilly Reports Third-Quarter 2023 Financial Results, Highlights Strong Sales Growth and Business Development Activity
7:02am
SC TO-T/A
EX-99
5znhc8v6028jq
9 Aug 23
Third party tender offer statement (amended)
9:14am
8-K
EX-99.1
oip3lvxxyjza90s
8 Aug 23
Lilly Reports Second-Quarter 2023 Financial Results, Highlights Accelerating Revenue Growth and Key Pipeline Advancements
7:01am
SC TO-T
EX-99
ckmf5a
13 Jul 23
Third party tender offer statement
8:01am
SC TO-T
EX-99
t035m9 io5m
30 Jun 23
Third party tender offer statement
4:06pm
SC TO-C
EX-99.1
uitksr
29 Jun 23
Information about tender offer
6:56am
SC TO-C
EX-99.1
rsqf0eqfkj6b
20 Jun 23
Information about tender offer
8:20am
PX14A6G
7pigy80lro
21 Apr 23
Letter to shareholders
2:02pm
8-K
EX-99
03vgjwjny36h99r
13 Dec 22
Lilly Announces 2023 Financial Guidance, Plans to Launch up to Four New Medicines
7:03am